ENTRADA THERAPEUTICS INC. - COMMON STOCK
11.22
12-三月-25 16:45:01
15 分钟延时
股票
+0.57
+5.35%
今日范围
10.64 - 11.27
ISIN
N/A
来源
NASDAQ
-
Entrada Therapeutics Appoints Karla MacDonald as Chief Corporate Affairs Officer
19 7月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Entrada Therapeutics to Present at William Blair Biotech Focus Conference
06 7月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
Entrada Therapeutics to Present at Goldman Sachs Global Healthcare Conference
01 6月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
Entrada Therapeutics Reports First Quarter 2022 Financial Results
12 5月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
11 5月 2022 09:30:00 条件 Nasdaq GlobeNewswire
-
Entrada Therapeutics to Present at H.C. Wainwright Global Investment Conference
10 5月 2022 07:00:03 条件 Nasdaq GlobeNewswire
-
Entrada Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
15 3月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Entrada Therapeutics to Participate in Cowen 42nd Annual Health Care Conference
23 2月 2022 08:00:02 条件 Nasdaq GlobeNewswire
-
Entrada Therapeutics Announces the Appointment of Jared Cohen, PhD, JD to General Counsel
05 1月 2022 08:00:03 条件 Nasdaq GlobeNewswire
-
Entrada Therapeutics to be Added to Russell 2000® and Russell 3000® Indexes
17 12月 2021 08:00:00 条件 Nasdaq GlobeNewswire
-
Entrada Therapeutics Reports Third Quarter 2021 Financial Results
09 12月 2021 07:00:00 条件 Nasdaq GlobeNewswire